Shares of Cellectis SA (NASDAQ:CLLS) have received an average broker rating score of 1.00 (Strong Buy) from the four analysts that cover the stock, Zacks Investment Research reports. Four equities research analysts have rated the stock with a strong buy recommendation. Brokers have set a 1-year consensus target price of $56.00 for the company and […]
